Today: 11 June 2026
Nike stock jumps after CEO Elliott Hill’s $1 million buy — what’s next for NKE
1 January 2026
1 min read

Nike stock jumps after CEO Elliott Hill’s $1 million buy — what’s next for NKE

NEW YORK, January 1, 2026, 08:08 ET — Market closed

  • Nike shares last closed up about 4% at $63.71 after CEO Elliott Hill disclosed an open-market buy.
  • A Form 4 filing showed Hill bought 16,388 shares at a weighted average $61.10.
  • Next catalysts include early-January U.S. data and Nike’s next earnings report on March 19.

Nike, Inc. shares rose 4.1% on Wednesday to close at $63.71 after Chief Executive Elliott Hill disclosed an open-market purchase of about $1 million in stock. Hill bought 16,388 Class B shares at a weighted-average $61.10 on Dec. 29, bringing his direct holdings to 241,587 shares, a Form 4 filing — the SEC’s required disclosure of insider trades — showed. The filing said the buy was executed in multiple transactions between $61.09 and $61.10.

Insider buying is closely watched because executives typically know their business best, and open-market purchases can signal confidence when investors are split on a turnaround.

That matters for Nike because the company is trying to rebuild momentum under Hill while it clears older inventory and navigates uneven demand across regions, including China.

Nike’s gain also stood out on a down day for the broader market as Wall Street closed out 2025 with a fourth straight daily decline, even though major indexes still posted annual gains. U.S. markets are closed on Thursday for New Year’s Day.

Hill’s buy follows other recent insider activity at Nike. Apple CEO Tim Cook, Nike’s lead independent director, bought 50,000 shares at $58.97 each in late December, and Baird analyst Jonathan Komp said, “(We see) Cook’s move as a positive signal for the progress under CEO Elliott Hill and Nike’s ‘Win Now’ actions,” Reuters reported. Reuters

Nike said on Dec. 18 that second-quarter revenue rose 1% to $12.4 billion, while gross margin — a key profitability measure — fell 300 basis points, or three percentage points, to 40.6%. Wholesale revenue rose 8% to $7.5 billion, while Nike Direct — sales through its own stores and digital channels — fell 8% to $4.6 billion, the company said. Inventories stood at $7.7 billion, down 3%.

Investors are now looking for signs that margin pressure eases as Nike refreshes key product lines and that wholesale strength can offset softness in its direct and digital channels. The next test is less about symbolism and more about execution: sell-through, inventory and guidance.

Nike’s outperformance contrasted with other athletic-wear names in the final session, with Deckers Outdoor down 1.3% and Under Armour shares falling more than 2%, according to MarketWatch.

Before the next U.S. trading session on Friday, investors will watch a run of economic releases that can sway expectations for consumer spending. The Labor Department’s schedule shows the December jobs report due on Jan. 9 and December CPI inflation due on Jan. 13.

Rate expectations remain a key cross-current for consumer discretionary stocks, including Nike. The Federal Reserve has penciled in its next policy meeting for Jan. 27-28.

Stock Market Today

  • Dollar Index Edges Up as Oil Prices Surge and Stocks Decline
    June 10, 2026, 5:59 PM EDT. The dollar index rose slightly by 0.06% on Wednesday, recovering from early losses. A more than 2% surge in WTI crude oil prices raised inflation expectations, supporting the U.S. dollar amid concerns over potential Federal Reserve monetary tightening. The U.S. May Consumer Price Index matched forecasts, with inflation still at a three-year high. Concurrently, geopolitical tensions between the U.S. and Iran increased safe-haven demand for the dollar. In Europe, the euro gained modestly amid expectations of a European Central Bank interest rate hike, though oil price gains restricted upside. The Japanese yen fell to a five-week low against the dollar, pressured by rising crude prices and U.S. Treasury yields, despite hawkish signals from Japan's producer price data and central bank.

Latest articles

Parabilis Medicines (PBLS) soars 58% after $670 million IPO beats range

Parabilis Medicines (PBLS) soars 58% after $670 million IPO beats range

10 June 2026
Parabilis Medicines soared 58% above its $20 IPO price to close at $31.60 in its Nasdaq debut after raising a record $670 million, reflecting strong investor demand for its Helicon drug platform ahead of a pivotal Phase 3 desmoid tumor trial planned for 2027; Regeneron’s $75 million private placement added credibility.
Joby Aviation Shares Slip After CFO Files to Sell Stock

Joby Aviation Shares Slip After CFO Files to Sell Stock

10 June 2026
Joby Aviation fell 4.47% to $8.86 after CFO Rodrigo Brumana disclosed selling 78,489 shares under a prearranged 10b5-1 plan, with no new certification or commercial-launch updates, leaving investors focused on regulatory progress and cash burn as the key catalysts for the stock.
YY Group Shares Spike as Humanoid Robot Plans Unveiled

YY Group Shares Spike as Humanoid Robot Plans Unveiled

10 June 2026
YY Group Holding shares surged to $0.165 on heavy volume after announcing a commercial humanoid-robotics initiative using Unitree G1 robots and facility-management data, reframing the company as a robotics-and-AI data play; the rally comes despite 2025 net loss, dilution risk from a relaunched at-the-market share-sale program, and no disclosed robot-related revenue or contracts.
Outlook Therapeutics stock drops after FDA issues another Lytenava CRL for wet AMD
Previous Story

Outlook Therapeutics stock drops after FDA issues another Lytenava CRL for wet AMD

Apple stock slips into 2026 as year-end tech pullback bites; AAPL earnings next
Next Story

Apple stock slips into 2026 as year-end tech pullback bites; AAPL earnings next

Go toTop